BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2017 11:08:21 AM | Browse: 1947 | Download: 2357
Publication Name World Journal of Cardiology
Manuscript ID 31115
Country United Kingdom
ISSN 1949-8462 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Minireviews
Article Title Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk
Manuscript Source Invited Manuscript
All Author List Thomas J Cahill and Rajesh K Kharbanda
Funding Agency and Grant Number
Corresponding Author Rajesh K Kharbanda, Professor, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, United Kingdom. rajesh.kharbanda@ouh.nhs.uk
Key Words Angioplasty; Heart failure; Myocardial infarc­tion; Percutaneous coronary intervention; ST-elevation myocardial infarction
Core Tip Heart failure (HF) is a major cause of late morbidity and mortality after myocardial infarction. Several approaches exist for early identification of patients at risk of HF, including clinical and angiographic scoring, cardiac imaging, and invasive coronary physiology, but these are currently poorly integrated. Here we provide an overview of the incidence, me­chanisms, and outcomes of HF following myocardial infarction in the era of primary percutaneous coronary intervention, and discuss HF risk-stratification for the individual patient. Looking ahead, accurate and early prediction of HF will allow targeting of novel therapeutic agents to high-risk patients before ventricular remodel­ling and clinical HF have become established.
Publish Date 2017-05-20 11:08
Citation Cahill TJ, Kharbanda RK. Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Me­chanisms, incidence and identification of patients at risk. World J Cardiol 2017; 9(5): 407-415
URL http://www.wjgnet.com/1949-8462/full/v9/i5/407.htm
DOI http://dx.doi.org/10.4330/wjc.v9.i5.407
Full Article (PDF) WJC-9-407.pdf
Full Article (Word) WJC-9-407.doc